back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-11-27 08:51 Tx date 2023-11-08 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-20,000 vol |
110,992 | |
| Filed 2023-08-23 12:50 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$470,000
+100,000 vol $4.70 each |
242,294 | |
| Filed 2023-05-29 14:09 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,996
+900 vol $4.44 each |
57,500 | |
| Filed 2023-05-19 13:21 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,986
+900 vol $4.43 each |
||
| Filed 2023-05-23 09:01 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,250
+2,500 vol $4.50 each |
67,500 | |
| Filed 2023-05-23 09:01 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,576
+800 vol $4.47 each |
65,000 | |
| Filed 2023-05-23 09:00 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,589
+3,900 vol $4.51 each |
64,200 | |
| Filed 2023-05-23 08:59 Tx date 2023-05-19 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,600
+2,800 vol $4.50 each |
60,300 | |
| Filed 2023-05-19 13:21 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,986
+900 vol $4.43 each |
57,500 | |
| Filed 2023-05-19 13:21 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,250
+2,500 vol $4.50 each |
56,600 | |
| Filed 2023-05-19 13:20 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,398
+4,700 vol $4.34 each |
54,100 | |
| Filed 2023-05-19 13:19 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,530
+1,700 vol $4.43 each |
49,400 | |
| Filed 2023-05-19 13:18 Tx date 2023-05-18 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$884.00
+200 vol $4.42 each |
47,700 | |
| Filed 2022-12-15 15:08 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$788,720
+78,872 vol $10.00 each |
130,992 | |
| Filed 2022-05-18 16:01 Tx date 2022-05-17 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,245
+500 vol $12.49 each |
47,500 | |
| Filed 2022-05-18 16:00 Tx date 2022-05-17 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,470
+1,000 vol $12.47 each |
47,000 | |
| Filed 2022-05-18 16:00 Tx date 2022-05-17 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,904
+800 vol $12.38 each |
46,000 | |
| Filed 2022-05-18 15:59 Tx date 2022-05-17 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,478
+200 vol $12.39 each |
45,200 | |
| Filed 2021-12-16 12:13 Tx date 2021-12-14 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,399
+100 vol $13.99 each |
45,000 | |
| Filed 2021-12-16 12:13 Tx date 2021-12-14 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,600
+900 vol $14.00 each |
44,900 | |
| Filed 2021-12-14 13:28 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,840
+400 vol $14.60 each |
44,000 | |
| Filed 2021-12-14 13:27 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,820
+400 vol $14.55 each |
43,600 | |
| Filed 2021-12-14 13:26 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,377
+300 vol $14.59 each |
43,200 | |
| Filed 2021-12-14 13:25 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,852
+400 vol $14.63 each |
42,900 | |
| Filed 2021-12-14 13:22 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$85,614
+5,852 vol $14.63 each |
||
| Filed 2021-12-14 13:22 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$63,860
+4,377 vol $14.59 each |
||
| Filed 2021-12-14 13:20 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$63,860
+4,377 vol $14.59 each |
||
| Filed 2021-12-14 13:19 Tx date 2021-12-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$85,614
+5,852 vol $14.63 each |
||
| Filed 2021-12-10 14:41 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$321,200
+32,120 vol $10.00 each |
52,120 | |
| Filed 2021-12-10 14:40 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$701,360
+46,417 vol $15.11 each |
142,294 | |
| Filed 2021-09-21 15:32 Tx date 2021-09-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$104,250
+12,500 vol $8.34 each |
42,500 | |
| Filed 2021-09-21 15:28 Tx date 2021-09-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-104,250
-12,500 vol $8.34 each |
95,877 | |
| Filed 2021-05-21 14:48 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,100
+300 vol $17.00 each |
30,000 | |
| Filed 2021-05-21 14:47 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,576
+800 vol $16.97 each |
29,700 | |
| Filed 2021-05-21 14:46 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,352
+1,200 vol $16.96 each |
28,900 | |
| Filed 2021-05-21 14:44 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,379
+200 vol $16.90 each |
27,700 | |
| Filed 2021-05-21 14:43 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,865
+700 vol $16.95 each |
27,500 | |
| Filed 2021-05-21 14:41 Tx date 2021-05-21 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,073
+300 vol $16.91 each |
26,800 | |
| Filed 2021-05-21 14:40 Tx date 2021-05-19 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,800
+1,000 vol $16.80 each |
26,500 | |
| Filed 2021-05-17 09:42 Tx date 2021-05-14 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,720
+100 vol $17.20 each |
25,500 | |
| Filed 2021-05-17 09:42 Tx date 2021-05-14 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,952
+400 vol $17.38 each |
25,400 | |
| Filed 2021-05-17 09:41 Tx date 2021-05-14 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,478
+200 vol $17.39 each |
25,000 | |
| Filed 2021-05-14 09:18 Tx date 2021-05-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+600 vol $17.50 each |
24,800 | |
| Filed 2021-05-14 09:17 Tx date 2021-05-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,004
+400 vol $17.51 each |
24,200 | |
| Filed 2021-05-14 09:17 Tx date 2021-05-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,915
+500 vol $17.83 each |
23,800 | |
| Filed 2021-05-14 09:16 Tx date 2021-05-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,556
+200 vol $17.78 each |
23,300 | |
| Filed 2021-05-14 09:16 Tx date 2021-05-12 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,775
+100 vol $17.75 each |
23,100 | |
| Filed 2020-11-18 16:33 Tx date 2020-11-13 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,400
+1,000 vol $15.40 each |
23,000 | |
| Filed 2020-11-13 14:52 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$200,000
+20,000 vol $10.00 each |
20,000 | |
| Filed 2020-11-13 14:51 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 12:41 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$389,000
+25,000 vol $15.56 each |
108,377 | |
| Filed 2019-06-11 10:51 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$659,615
+42,419 vol $15.55 each |
83,377 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,509
+28,958 vol $8.34 each |
40,958 | |
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,000 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Hendrickson, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
22,000 |